GH Research (STU:1KA) Beginning Cash Position : €86.01 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is GH Research Beginning Cash Position?

GH Research's Beginning Cash Position for the quarter that ended in Dec. 2024 was €86.01 Mil.

GH Research's quarterly Beginning Cash Position increased from Jun. 2024 (€71.98 Mil) to Sep. 2024 (€78.51 Mil) and increased from Sep. 2024 (€78.51 Mil) to Dec. 2024 (€86.01 Mil).

GH Research's annual Beginning Cash Position declined from Dec. 2022 (€261.28 Mil) to Dec. 2023 (€152.18 Mil) and declined from Dec. 2023 (€152.18 Mil) to Dec. 2024 (€74.89 Mil).

GH Research Beginning Cash Position Historical Data

The historical data trend for GH Research's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GH Research Beginning Cash Position Chart

GH Research Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

0.41

5.22

261.28

152.18

74.89

GH Research Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Beginning Cash Position	Get a 7-Day Free Trial															79.27	72.15	71.98	78.51	86.01

GH Research Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

GH Research Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of GH Research's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

GH Research Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (STU:1KA) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

GHRS:USA

Address

Dawson Street, Joshua Dawson House, Dublin 2, IRL, D02 RY95

Website

https://www.ghres.com

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

GH Research Headlines

No Headlines